# MedFindr — Developer Notes

## v1.2 — Final audit and SignalGraph refinement

v1.2 builds on the v1.1 reliability foundation without replacing the working architecture.

### v1.2 implementation

- Added a lightweight normalized clinical-information model.
- Added medication-exposure relationship extraction.
- Added a prototype medication-related safety-signal layer.
- Added explicit evidence/provenance objects.
- Added input completeness/data-quality reporting.
- Added an in-memory development trace with a non-content-derived analysis identifier.
- Extended the Technical view to expose structured data and development trace information.
- Added a synthetic SignalGraph evaluation dataset and evaluation script.
- Preserved the existing urgency engine, EBM boundary, OpenFDA adapter, validation layer, and regression suite.

### Final audit findings and refinements

A repository-wide audit was performed against the v1.2 development branch, including repository structure, branches, recent commits, pull request state, workflow runs, core source modules, tests, evaluation scripts, configuration, requirements, and documentation.

The audit found the v1.2 pipeline functionally coherent, but identified several quality issues worth correcting before treating the branch as a clean portfolio milestone:

- Removed an awkward conditional-expression workaround from the response engine and replaced it with explicit StructuredResponse construction.
- Replaced the deterministic hash-derived analysis identifier with a random short identifier so the trace identifier is not derived from supplied concern text.
- Changed trace wording from “auditable” to “development trace” to avoid implying a compliance-grade audit log.
- Changed UI labels from “Patient / Staff” to “General / Technical” because the prototype has no patient identity, authentication, or staff authorization model.
- Updated the test-suite version wording from v1.1 to v1.2 while preserving the v1.1 regression coverage.
- Tightened wording around public label retrieval and prototype safety signals.
- Rechecked temporary/TODO/placeholder markers and found no unfinished implementation marker in production code. Remaining ExampleMedicine and example.test strings are confined to synthetic tests.
- Restored the complete v1.1 regression suite after an audit edit briefly replaced it with a shortened file, then verified the restored suite from a clean clone.
- Corrected the control-character regression test so its null-byte escape is represented safely in source code.
- Re-ran the complete verification suite after all corrections.

### Engineering boundary

The SignalGraph layer is intentionally a pattern detector. It does not infer that a drug caused an event, diagnose, prescribe, recommend treatment, or act as a clinical alerting system.

The development trace is intentionally in-memory. It is useful for understanding the software path during development but is not a compliant audit log and should not be presented as one.

### Deliberately unchanged

- Existing urgency rules and regression fixes
- Cached EBM loading boundary
- OpenFDA retrieval boundary
- No-database architecture
- No-authentication architecture
- Small-project implementation style

### Deliberately not implemented

OMOP/FHIR implementation, patient records, authentication, hospital/device integrations, real-time alerting, autonomous diagnosis, large AI/LLM features, and production infrastructure.

These additions would require separate requirements, validation, security controls, governance, and testing rather than being added merely to make the repository look larger.

### Final verification

Latest clean v1.2 development-branch verification:

- Python compilation: passed
- Automated tests: 24/24 passed
- Urgency evaluation: 15/15 labelled cases matched
- SignalGraph evaluation: 8/8 synthetic cases matched
- Source-marker scan: no unfinished implementation markers found in production code
- Stale user-facing v1.0/v1.1 product-version scan: clear
- Git working tree from clean clone: clean
- GitHub Actions: configured to rerun on the latest v1.2 commits

These fixtures test software behavior only. They do not establish clinical safety, efficacy, pharmacovigilance performance, diagnostic accuracy, or generalization.

### Repository state

- v1.2-development contains the audited v1.2 candidate.
- main remains the verified v1.1 baseline until the v1.2 pull request is deliberately merged.
- Pull request #1 tracks the v1.2 promotion into main.
- Repository default branch is now main.
- Repository description and topics are aligned with the v1.2 scope.

### Project authorship

MedFindr is a student-built project created and directed by Pushkar Sable. External assistance is used selectively for debugging, research, review, and implementation support; the project concept, direction, scope decisions, repository ownership, and final acceptance decisions remain with the creator.
